Skip to content
  • 6,812 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Special notice

Health Sector Supply Chain Fragility and Investment Prioritization Support Services

77344426S0002

United States International Development Finance Corporation, Office of Acquisition. Pharmaceutical Preparation Manufacturing.

Response deadline

August 31, 2026 at 4:30 PM EDT

Closed 62 days ago. Posted August 27, 2026. Scheduled to archive September 15, 2026.

Get the next one like this from United States International Development Finance Corporation by email, the day it is posted.Find my opportunities

This one closed in 2026

9 like it are open now in pharmaceutical preparation manufacturing

All 9 open in pharmaceutical preparation manufacturing

Description

As published on SAM.gov.

Notice of Sole Source Intent 

The U.S. International Development Finance Corporation (DFC) intends to award a one-year, sole source purchase order to API Innovation Center (APIIC) for specialized analytical, technical, data integration, prioritization, reporting, and briefing support to identify, assess, prioritize, and act on pharmaceutical and health-sector supply chain vulnerabilities that may present development finance, investment, counter-dependency, resilience, and strategic supply chain opportunities.  The requirement is for a highly specialized contractor capable of producing a national fragility analysis; integrating multiple pharmaceuticals, manufacturing, regulatory, utilization, geopolitical, and risk datasets; assessing API-level supply chain dependency; supporting DFC-calibrated model weighting; prioritizing candidate drugs; and preparing approximately 20–30 drug-specific supply chain reports. The work requires detailed visibility into active pharmaceutical ingredient (API) production, finished dosage form (FDF) manufacturing, key starting material (KSM) and upstream dependencies, manufacturer and facility-level concentration, country-specific dependency risks, and financeable opportunities to reduce supply chain fragility.

This contract action is for services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). Interested vendors may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received by Monday, August 31, 2026, at 4:30pm Eastern Time (ET) will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the Contracting Officer, Melissa Hergenrader, at melissa.hergenrader@dfc.gov by Monday, August 31, 2026, at 4:30pm ET.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 27, 2026

    Special notice

    Due August 31, 2026 at 4:30 PM EDT. SAM.gov, notice 8bb80217267a4e4eb12ca5bc59faf17a

    1 revisions on SAM
    • August 27, 2026: publish, special notice

Points of contact